AT207744T - fatty acids omega-3 new use of - Google Patents

fatty acids omega-3 new use of

Info

Publication number
AT207744T
AT207744T AT93905710T AT93905710T AT207744T AT 207744 T AT207744 T AT 207744T AT 93905710 T AT93905710 T AT 93905710T AT 93905710 T AT93905710 T AT 93905710T AT 207744 T AT207744 T AT 207744T
Authority
AT
Austria
Prior art keywords
fatty acids
new use
acids omega
omega
new
Prior art date
Application number
AT93905710T
Other languages
German (de)
Inventor
Nils Egberg
Carin Larsson-Backstroem
Jan Jakobsson
Rolf Lundh
Original Assignee
Fresenius Kabi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SE9200541A priority Critical patent/SE9200541D0/en
Application filed by Fresenius Kabi Ab filed Critical Fresenius Kabi Ab
Priority to PCT/SE1993/000146 priority patent/WO1993016691A1/en
Publication of AT207744T publication Critical patent/AT207744T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/55Linaceae (Flax family), e.g. Linum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/824Arteriosclerosis
AT93905710T 1992-02-24 1993-02-23 fatty acids omega-3 new use of AT207744T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE9200541A SE9200541D0 (en) 1992-02-24 1992-02-24 New usee of omega-3 fatty acids
PCT/SE1993/000146 WO1993016691A1 (en) 1992-02-24 1993-02-23 New use of omega-3-fatty acids

Publications (1)

Publication Number Publication Date
AT207744T true AT207744T (en) 2001-11-15

Family

ID=20385410

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905710T AT207744T (en) 1992-02-24 1993-02-23 fatty acids omega-3 new use of

Country Status (13)

Country Link
US (2) US5747533A (en)
EP (1) EP0627918B1 (en)
JP (1) JP3559280B2 (en)
AT (1) AT207744T (en)
AU (1) AU671438B2 (en)
CA (1) CA2117535A1 (en)
DE (2) DE69331051D1 (en)
DK (1) DK0627918T3 (en)
ES (1) ES2162620T3 (en)
NO (1) NO309704B1 (en)
SE (1) SE9200541D0 (en)
SG (1) SG46238A1 (en)
WO (1) WO1993016691A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0987176A (en) * 1995-09-26 1997-03-31 Shiseido Co Ltd Agent for suppressing glomerular nephritis
EP1004303B1 (en) * 1997-06-16 2004-10-13 Nippon Suisan Kaisha, Ltd. Composition having capability of removing risk factor during exercise
US6054481A (en) 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
JP4754688B2 (en) * 1998-01-21 2011-08-24 フィドゥランFideline Pig sedation pheromone that reduces stress, anxiety and aggression
JP4750232B2 (en) * 1998-01-21 2011-08-17 フィドゥランFideline Porcine sedative pheromone reduces stress, anxiety and aggression
EP1220669A4 (en) * 1999-10-13 2004-12-08 Marco A Chacon Therapeutic intervention to mimic the effect of caloric restriction
FR2804023B1 (en) * 2000-01-26 2002-09-20 Johnson & Johnson Consumer Fr Nutritional Supplement to base Blackcurrant pips oil
WO2002069964A1 (en) * 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
US8729124B2 (en) * 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
WO2006036964A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Barrier layer
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20060067977A1 (en) 2004-09-28 2006-03-30 Atrium Medical Corporation Pre-dried drug delivery coating for use with a stent
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
WO2006136962A2 (en) * 2005-06-24 2006-12-28 Drugrecure Aps Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract
AU2007214127A1 (en) * 2006-02-10 2007-08-16 Sportscom Danmark Aps Coated tablets, their methods of preparation, and related uses
US8574627B2 (en) 2006-11-06 2013-11-05 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US20080207756A1 (en) * 2007-02-27 2008-08-28 Atrium Medical Corporation Bio-absorbable oil suspension
US20090011012A1 (en) * 2007-07-06 2009-01-08 Baum Seth J Fatty acid compositions and methods of use
EP2214481B1 (en) 2007-10-15 2019-05-01 United Animal Health, Inc. Method for increasing performance of offspring
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US20100010088A1 (en) * 2007-11-01 2010-01-14 Wake Forest University School Of Medicine Compositions and Methods for Prevention and Treatment of Mammalian Diseases
WO2009070589A1 (en) * 2007-11-30 2009-06-04 Jbs United, Inc. Method and composition for treating pulmonary hemorrhage
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US20110045050A1 (en) * 2009-08-24 2011-02-24 Atrium Medical Corporation Nanoemulsion formulations for direct delivery
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
WO2011103514A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha triglyceride emulsions
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9549937B2 (en) 2013-12-05 2017-01-24 Burvia, LLC. Composition containing phospholipid-DHA and folate
US9610302B2 (en) 2013-12-05 2017-04-04 Buriva, LLC. Composition containing phospholipid-DHA and B vitamins
US9233114B2 (en) 2013-12-05 2016-01-12 Buriva, LLC Dietary supplement containing phospholipid-DHA derived from eggs
US9216199B2 (en) 2013-12-05 2015-12-22 Buriva, LLC Nutritional supplement containing phospholipid-DHA derived from eggs
US9655847B1 (en) * 2016-07-18 2017-05-23 National Guard Health Affairs Therapeutic liposome and method of treating a subject having cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
AT88631T (en) * 1986-09-17 1993-05-15 Clintec Nutrition Co Additional food or therapy for people with risk or under treatment for atherosclerotic, vascular, cardiovascular and / or thrombotic disorders.
DE3719097C1 (en) * 1987-06-06 1988-06-09 Fratzer Uwe A pharmaceutical composition containing EPA and DHA as unsaturated fatty acids and vitamin E
GB8729751D0 (en) * 1987-12-21 1988-02-03 Norsk Hydro As Feed additive & feed containing such additive
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients

Also Published As

Publication number Publication date
JP3559280B2 (en) 2004-08-25
NO309704B1 (en) 2001-03-19
US5747533A (en) 1998-05-05
AU3652993A (en) 1993-09-13
CA2117535A1 (en) 1993-09-02
SE9200541D0 (en) 1992-02-24
DK0627918T3 (en) 2002-01-14
AU671438B2 (en) 1996-08-29
DE69331051T2 (en) 2002-06-13
SG46238A1 (en) 1998-02-20
JPH07507766A (en) 1995-08-31
DE69331051D1 (en) 2001-12-06
EP0627918B1 (en) 2001-10-31
DK627918T3 (en)
NO943102L (en) 1994-10-21
EP0627918A1 (en) 1994-12-14
WO1993016691A1 (en) 1993-09-02
US5731346A (en) 1998-03-24
NO943102D0 (en) 1994-08-23
ES2162620T3 (en) 2002-01-01

Similar Documents

Publication Publication Date Title
DE19681286T1 (en) New crystal form of olanzapine
DE69323431T2 (en) Production of solid materials
DE69315391D1 (en) Circuit to eliminate interference
FI935804A0 (en) Foerfarande Foer papperstillverkning under anvaendande of tvaerbundna katjoniska / amfoteriska staerkelser
BR8501597A (en) Composition of polyester
DE69510190T2 (en) Use of fatty acid ester as bioadhesives
DE69210054T2 (en) Carbonylation of olefins
DE69331324D1 (en) New glucan-preparation
DE69328668T2 (en) One-step process for the preparation of alkenylsuccinic anhydrides
DE69529470T2 (en) phosphate esters Emulgiermittelzusammensetzungen on the basis of fatty alcohol
DE507591T1 (en) Anionenaustauschtrennung of nucleic acids.
FI934579A (en) Polymerisationsreaktioner i gasfas under anvaendning of loesliga icke-Burna katalysatorer
DE3856198T2 (en) Interactive Inbewegungbringen of graphical objects
NO934681D0 (en) Surface inspection of broenn-annulus
DE69232985D1 (en) Mixture of carboxylic acids as sanitizers
DE69722182D1 (en) Di-esters of polymerized fatty acids for use in hot-melt-inks
DE706657T1 (en) Interactions of inhibierungsproteinen
AT209968T (en) Spraying of liquids
DE3519429A1 (en) A process for the transesterification of fats and oils and enzympraeparat
DE69329856D1 (en) Ester derivatives of 4-aza-steroidal
DE68926977T2 (en) Cleaning of fish oil
DE69304807T2 (en) Enteric microspheres containing buffered bile acids
AT189966T (en) Activation of photosensitive agents
DE59302756D1 (en) Connection of components
MX9101551A (en) Unsaturated acids of hidroxialquilquinolina as leukotriene antagonists

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification